Cargando…

Synchronous Double Primary Cancer Complicated With Severe Hypercalcemia

Hypercalcemia of malignancy (HCM) is an important cancer-related medical emergency. It is a sign of advanced disease with a poor prognosis. We report a case of a 55-year-old man who presented with decreased sensorium, constipation for 4 days, dysphonia, and weight loss for the past three months. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Alçada, Martim, Gaspar, Vasco, Cunha, Guilherme, Manata, José Pedro, Roque, Filomena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10530228/
https://www.ncbi.nlm.nih.gov/pubmed/37772252
http://dx.doi.org/10.7759/cureus.44272
_version_ 1785111488965378048
author Alçada, Martim
Gaspar, Vasco
Cunha, Guilherme
Manata, José Pedro
Roque, Filomena
author_facet Alçada, Martim
Gaspar, Vasco
Cunha, Guilherme
Manata, José Pedro
Roque, Filomena
author_sort Alçada, Martim
collection PubMed
description Hypercalcemia of malignancy (HCM) is an important cancer-related medical emergency. It is a sign of advanced disease with a poor prognosis. We report a case of a 55-year-old man who presented with decreased sensorium, constipation for 4 days, dysphonia, and weight loss for the past three months. The physical examination showed a petrous nodular lesion of the neck in relation to the right sternocleidomastoid muscle. The digital rectal examination showed an enlarged prostate with a nodule of hard consistency. The blood revealed a hypercalcemia of 18.9 mg/dl and a prostate-specific antigen of 319.18 ng/ml. After further investigation, we discovered a squamous cell carcinoma of the larynx with multiple osteolytic bone lesions and a prostate adenocarcinoma. The hypercalcemia was treated with sodium pamidronate with good results. Such severe hypercalcemia demanded further research which revealed that not only the osteolytic lesions contributed to the elevation of calcium serum levels but also the tumor secretion of parathyroid hormone-related protein. This case highlights the importance of not only having a high suspicion for malignancy in patients presenting with hypercalcemia but also being aware of possible additional diagnoses in a patient with an already identified primary pathology. 
format Online
Article
Text
id pubmed-10530228
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-105302282023-09-28 Synchronous Double Primary Cancer Complicated With Severe Hypercalcemia Alçada, Martim Gaspar, Vasco Cunha, Guilherme Manata, José Pedro Roque, Filomena Cureus Internal Medicine Hypercalcemia of malignancy (HCM) is an important cancer-related medical emergency. It is a sign of advanced disease with a poor prognosis. We report a case of a 55-year-old man who presented with decreased sensorium, constipation for 4 days, dysphonia, and weight loss for the past three months. The physical examination showed a petrous nodular lesion of the neck in relation to the right sternocleidomastoid muscle. The digital rectal examination showed an enlarged prostate with a nodule of hard consistency. The blood revealed a hypercalcemia of 18.9 mg/dl and a prostate-specific antigen of 319.18 ng/ml. After further investigation, we discovered a squamous cell carcinoma of the larynx with multiple osteolytic bone lesions and a prostate adenocarcinoma. The hypercalcemia was treated with sodium pamidronate with good results. Such severe hypercalcemia demanded further research which revealed that not only the osteolytic lesions contributed to the elevation of calcium serum levels but also the tumor secretion of parathyroid hormone-related protein. This case highlights the importance of not only having a high suspicion for malignancy in patients presenting with hypercalcemia but also being aware of possible additional diagnoses in a patient with an already identified primary pathology.  Cureus 2023-08-28 /pmc/articles/PMC10530228/ /pubmed/37772252 http://dx.doi.org/10.7759/cureus.44272 Text en Copyright © 2023, Alçada et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Internal Medicine
Alçada, Martim
Gaspar, Vasco
Cunha, Guilherme
Manata, José Pedro
Roque, Filomena
Synchronous Double Primary Cancer Complicated With Severe Hypercalcemia
title Synchronous Double Primary Cancer Complicated With Severe Hypercalcemia
title_full Synchronous Double Primary Cancer Complicated With Severe Hypercalcemia
title_fullStr Synchronous Double Primary Cancer Complicated With Severe Hypercalcemia
title_full_unstemmed Synchronous Double Primary Cancer Complicated With Severe Hypercalcemia
title_short Synchronous Double Primary Cancer Complicated With Severe Hypercalcemia
title_sort synchronous double primary cancer complicated with severe hypercalcemia
topic Internal Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10530228/
https://www.ncbi.nlm.nih.gov/pubmed/37772252
http://dx.doi.org/10.7759/cureus.44272
work_keys_str_mv AT alcadamartim synchronousdoubleprimarycancercomplicatedwithseverehypercalcemia
AT gasparvasco synchronousdoubleprimarycancercomplicatedwithseverehypercalcemia
AT cunhaguilherme synchronousdoubleprimarycancercomplicatedwithseverehypercalcemia
AT manatajosepedro synchronousdoubleprimarycancercomplicatedwithseverehypercalcemia
AT roquefilomena synchronousdoubleprimarycancercomplicatedwithseverehypercalcemia